Literature DB >> 15740535

Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease.

I Pache1, M Bilodeau.   

Abstract

BACKGROUND: Bleeding is a recognized complication of abdominal paracentesis. Special concern has been raised when it is performed in patients with liver failure because of coagulation disorders and collaterals in the abdominal wall. AIM: To assess the clinical characteristics of patients who developed haemorrhagic complications after paracentesis.
METHODS: We reviewed all cases of severe haemorrhage occurring after paracentesis in patients admitted to the Liver Unit of our institution between 1994 and 2004.
RESULTS: Nine cases were identified among 4729 procedures. The occurrence of severe haemorrhage represented 0.19% of all procedures with a death rate of 0.016%. Bleeding was not related to operator experience, elevated international normalized ratio or low platelets. It occurred in patients with high model for end-stage liver disease and Child-Pugh scores. Furthermore, some degree of renal failure was present in all but one patient.
CONCLUSION: Severe haemorrhage after abdominal paracentesis in patients with liver disease occurs in 0.2% of cases. It occurs in patients with severe liver failure and is often associated with significant pre-existing renal dysfunction.

Entities:  

Mesh:

Year:  2005        PMID: 15740535     DOI: 10.1111/j.1365-2036.2005.02387.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  43 in total

1.  Spontaneous bacterial peritonitis: few additional points.

Authors:  Pankaj Jain
Journal:  World J Gastroenterol       Date:  2009-12-07       Impact factor: 5.742

2.  Safety of Ascitic Paracentesis in Patients with Budd-Chiari Syndrome on Oral Anticoagulation and Elevated International Normalized Ratio.

Authors:  Harshad Devarbhavi; Arvind R Murali
Journal:  J Clin Exp Hepatol       Date:  2015-09-01

3.  Coagulopathy in cirrhosis: A prospective study to correlate conventional tests of coagulation and bleeding following invasive procedures in cirrhotics.

Authors:  Apurva Shah; Deepak Amarapurkar; Mrudul Dharod; Madhuri Chandnani; Rajiv Baijal; Praveen Kumar; Mayank Jain; Nikhil Patel; Praful Kamani; Sonali Gautam; Nimish Shah; Sandeep Kulkarni; Soham Doshi
Journal:  Indian J Gastroenterol       Date:  2015-09

4.  Acute kidney injury, but not sepsis, is associated with higher procedure-related bleeding in patients with decompensated cirrhosis.

Authors:  Adelina Hung; Guadalupe Garcia-Tsao
Journal:  Liver Int       Date:  2018-02-24       Impact factor: 5.828

5.  Diagnosis and management of delayed hemoperitoneum following therapeutic paracentesis.

Authors:  Morgan J Katz; Matthew N Peters; John D Wysocki; Chayan Chakraborti
Journal:  Proc (Bayl Univ Med Cent)       Date:  2013-04

6.  Recommendations on the Use of Ultrasound Guidance for Adult Abdominal Paracentesis: A Position Statement of the Society of Hospital Medicine.

Authors:  Joel Cho; Trevor P Jensen; Kreegan Reierson; Benji K Mathews; Anjali Bhagra; Ricardo Franco-Sadud; Loretta Grikis; Michael Mader; Ria Dancel; Brian P Lucas; Nilam J Soni
Journal:  J Hosp Med       Date:  2019-01-02       Impact factor: 2.960

7.  Cirrhotic ascites review: Pathophysiology, diagnosis and management.

Authors:  Christopher M Moore; David H Van Thiel
Journal:  World J Hepatol       Date:  2013-05-27

8.  Hemorrhagic ascites. Clinical presentation and outcomes in patients with cirrhosis.

Authors:  Nathalie H Urrunaga; Amit G Singal; Jennifer A Cuthbert; Don C Rockey
Journal:  J Hepatol       Date:  2013-01-21       Impact factor: 25.083

Review 9.  Spontaneous bacterial peritonitis.

Authors:  Anastasios Koulaouzidis; Shivaram Bhat; Athar A Saeed
Journal:  World J Gastroenterol       Date:  2009-03-07       Impact factor: 5.742

Review 10.  An evidence-based manual for abdominal paracentesis.

Authors:  Angela McGibbon; Grant I Chen; Kevork M Peltekian; Sander Veldhuyzen van Zanten
Journal:  Dig Dis Sci       Date:  2007-03-28       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.